The former CFO who orchestrated Nobel Laureates, revolutionized NFL safety, and proved your outsider status is your greatest ...
Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...
Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...
The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...
The fix to micromanaging is clearer decision rights, faster closure and visible accountability, so leaders can lead and the ...
The high-dose regimen of SPINRAZA (nusinersen) is approved in the European Union and Japan. The high-dose regimen is under review with the United States Food and Drug Administration (FDA) and has a ...
Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to 2029—click here to read now.
The E-Commerce & Digital Marketing Association (ECDMA) announces the admission of Aleksei Sovetkin to its Senior Member tier, ...
The results reinforce the need for individualized, biology-driven therapeutic decisions in patients with MS. SAN DIEGO – Older patients with MS had increased neuroaxonal and astroglial injury ...
A prior case already exempted certain partnership income from self-employment taxes in Texas, Louisiana and Mississippi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results